That the House of Representatives—
recognizes the vital importance of decreasing cardiovascular disease among women;
promotes the necessity of raising awareness of the preventable ubiquity of cardiovascular mortality among women, and urges a comprehensive public awareness initiative that establishes best practices for identifying and treating cardiovascular incidents in women, specifically;
supports efforts to educate women, men, patients, and physicians about the critical differences of cardiovascular disease symptoms between women and men;
supports the promotion of gender-specific cardiovascular health research, prevention, and treatment, because—
there is a material difference in the way women present with cardiovascular or heart attack symptoms; and
gender-specific cardiovascular research is essential to driving successful positive outcomes in the reduction of mortality rates;
affirms the connection between cardiovascular disease and preeclampsia in new mothers;
acknowledges that the costs to the health care system of unrecognized symptoms in the treatment of women can be substantially reduced with appropriate public policy; and
supports the development of economic impact data to ascertain the health care system costs to be saved by decreasing the incidents of death due to unrecognized symptoms of heart attack in women.